Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ONCT | Oncternal Therapeutics, Inc. | Chief Financial Officer | $73.1K | Feb 14, 2024 | ||
FBRX | Forte Biosciences, Inc. | Director | Sep 17, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|